Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today commented
on the ruling in the United States District Court for the Central
District of California in the Company’s federal securities litigation
against Valeant Pharmaceuticals International, Inc. (“Valeant”),
Pershing Square Capital Management, L.P. (“Pershing Square”) and its
principal, William A.
for Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square investment picks